The Prevalence of Alzheimer’s disease, Glaucoma and Age-related Macular Degeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$4,000
Active Dates
January 01, 2013 - October 11, 2013
Grant ID
CA2013001
Summary
The purpose of this report is to consolidate information on the individual and joint prevalence of Alzheimer’s disease, age-related macular degeneration (AMD) and glaucoma. In this report, the most current and robust sources for prevalence of each condition are identified and the joint prevalence of each combination of disease is calculated. While correlation of risk is likely to exist among these diseases, currently available evidence does not support the estimation of any such correlation. Thus, the prevalence results in this report are based on an assumption of independence of risk for each disease. This produces a conservative estimation of the prevalent population suffering from more than one disease. This report can serve as a guide to illustrate the probable prevalence of each of the three diseases and combinations of each in the US population by age. We calculated the prevalent population with each disease based on reported prevalence rates by age, and population by age identified in the 2010 US census. The following results are based on the latest evidence in the literature on the prevalence of each disease, as measured through gold-standard diagnosis criteria in community settings. Thus, these represent the true prevalence rate, including undiagnosed cases.
Grants
Related Grants
Alzheimer's Disease Research
Expanding and Enhancing LASI-DAD for Better Understanding of Alzheimer's Disease and Dementia
Active Dates
April 01, 2023 - March 31, 2025

Principal Investigator
Jinkook Lee, PhD
Current Organization
University of Southern California
Alzheimer's Disease Research
Advancing the Promising Cerebroprotectant AST-004 to Human Clinical Trials
Active Dates
July 02, 2021 - June 30, 2024

Principal Investigator
William Korinek, PhD
Current Organization
Astrocyte Pharmaceuticals
Alzheimer's Disease Research
Molecular Neurodegeneration Journal
Active Dates
March 31, 2021 - March 30, 2026

Principal Investigator
Owen Ross, PhD
Current Organization
Mayo Clinic Jacksonville